Conference - London, United Kingdom
A unique opportunity to build new relationships and improve existing partnerships between industry and patient organisations
Clarifying Regulations for Orphan Drugs with case-studies & recommendations to help you overcome common pitfalls in adhering to drug development regulations
Benchmark your orphan drug development programme against leading players such as Pfizer, GSK, Roche & NPS Pharma
Overcome challenges and gain solutions for small populations, critical considerations for trial design & strategies to boost patient enrollment & retention
Improve partnerships with patient organisations with critical recommendations for effective partnering
Get the most from your joint HTA/EMA meeting with critical insight and first-hand advice from NICE
Understand off-label use and its implications for product approval
Arrange one-to-one meetings with key stakeholders via EBD’s partnering system, groupsPLUS
Organization: Informa Life Sciences
Tue, Feb 24, 2015 - Wed, Feb 25, 2015
Park Plaza Victoria London
239 Vauxhall Bridge Road, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
